date:May 31, 2013
the first four months of life.
The study was set up in a large randomised, double-blind, placebo-controlled design including 252 formula-fed, healthy infants recruited within the first four weeks of life and 131 breast-fed infants. The infant formula was supplemented with 0.8g/100ml of Orafti Synergy1 or with maltodextrin in the control group. Formulas were provided until the age of four months. During the intervention period, measurements included normal growth, formula intake and acceptance,